Pharmaxis Ltd

Press Releases


You will need the Adobe Acrobat Reader 7.0 to view the PDF.
If you do not have any of the above, please download "Acrobat Reader".

  • 2006-December-14
  • Pharmaxis Appoints Dutch Distributor for Aridol (in PDF)
  • 2006-November-22
  • US Fast-Tracks Pharmaxis Cystic Fibrosis Drug (in PDF)
  • 2006-November-16
  • Aridol Endorsed in Global and Australian Guidelines (in PDF)
  • 2006-November-16
  • Pharmaxis Reports Phase III Results for Aridol (in PDF)
  • 2006-November-15
  • Pharmaxis Appoints New Board Director (in PDF)
  • 2006-October-26
  • 2006 Annual General Meeting Chairman's Address (in PDF)
  • 2006-October-25
  • Pharmaxis' Aridol Gains Swedish Approval (in PDF)
  • 2006-October-19
  • Pharmaxis Appoints Aridol Distributor for Italy (in PDF)
  • 2006-October-6
  • Pharmaxis Receives UK Approval for Phase III Cystic Fibrosis Trial (in PDF)
  • 2006-October-3
  • Pharmaxis Appoints Aridol Distributor for Greece (in PDF)
  • 2006-September-22
  • Pharmaxis Board Change (in PDF)
  • 2006-August-28
  • Pharmaxis U.S. Phase III Aridol Trial Closed (in PDF)
  • 2006-August-4
  • Pharmaxis Investor Conference Call (in PDF)
  • 2006-July-21
  • Aridol Marketing Application Filed in Switzerland (in PDF)
  • 2006-June-30
  • Pharmaxis' First Commercial Supply of Aridol to U.S. Market (in PDF)
  • 2006-May-2
  • Pharmaxis Reports End of Phase II Meeting with FDA and EMEA Protocol Assistance Meeting (in PDF)
  • 2006-April-19
  • Pharmaxis Enrols First Patient in Phase III Bronchiectasis Trial (in PDF)
  • 2006-April-11
  • Pharmaxis Completes Enrolment in Aridol COPD Trial (in PDF)
  • 2006-April-11
  • Pharmaxis Board Change (in PDF)
  • 2006-April-6
  • Pharmaxis Secures Licence for Dry Powder Manufacture (in PDF)
  • 2006-March-23
  • Pharmaxis' First Product, Aridol, Approved by Therapeutic Goods Administration (in PDF)
  • 2006-March-20
  • Majority of Pharmaxis Board Now Independent (in PDF)
  • 2006-March-16
  • Dr Peter Farrell Joins Pharmaxis Board (in PDF)
  • 2006-March-3
  • Pharmaxis Admitted to S&P/ASX 300 and All Ordinaries Indices (in PDF)
  • 2006-February-13
  • Aridol Recommended for Market Authorisation by ADEC (in PDF)
  • 2006-February-6
  • Pharmaxis Signs Swiss Marketing Partner for Aridol (in PDF)
  • 2006-February-6
  • Pharmaxis Commences Operations in Europe (in PDF)
  • 2006-January-18
  • Pharmaxis Signs First Distributor for Aridol (in PDF)
  • 2008
  • 2008 Press Releases
  • 2007
  • 2007 Press Releases
  • 2005
  • 2005 Press Releases
  • 2004
  • 2004 Press Releases


  • Company's Index
  • irasia.com

  • © Copyright 1996-2008 irasia.com Ltd. All rights reserved.
    DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd be liable for damages resulting from the use of the information provided on this website.
    TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited.
    TERMS OF USE: Please read the Terms of Use governing the use of our website.